Webinar Date/Time: Tue, Oct 17, 2023 10:00 AM EDT
Protein A chromatography capture steps typically use 20-cm bed heights. This can often lead to longer processing times and reduces cost-effectiveness, particularly in clinical trials where the full capacity of the resin is not utilized. This webinar explores innovative strategies and practical applications to increase resin utility, resulting in improvements in costs and time efficiencies in Protein A affinity capture.
Register Free: https://www.biopharminternational.com/bp_w/process-intensification-strategies
Event Overview:
Protein A chromatography capture steps typically use 20-cm bed heights. This can often lead to longer processing times and reduces cost-effectiveness, particularly in clinical trials where the full capacity of the resin is not utilized. In many instances, this may be the reason for higher overall downstream processing costs, and, disproportionately, higher costs of the Protein A affinity capture step.
This webinar explores innovative strategies and practical applications to increase resin utility, resulting in improvements in costs and time efficiencies in Protein A affinity capture.
Key Learning Objectives:
Who Should Attend:
Speaker:
Dr William Bowen
Field Applications Specialist, Bioprocess Chromatography Resins
Purolite, an Ecolab Company
Dr. William Bowen is a field applications specialist for bioprocess chromatography resins at Purolite, an Ecolab Company. Covering western Europe, he is responsible for providing technical support to customers in the use of Purolite’s resins at process development through to commercial manufacture. William completed his Master’s and PhD in Chemical Engineering at Loughborough University. He recently joined Purolite in January 2023.
Register Free: https://www.biopharminternational.com/bp_w/process-intensification-strategies
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.